Skip to main content
. 2023 Jul 4;4:1126012. doi: 10.3389/falgy.2023.1126012

Figure 9.

Figure 9

AmBisome nor Feraheme modify cell population and activation statuses in immunophenotyping panel #2. PBMC were treated with positive controls (LPS/PHA-M or PMA/Ionomycin), negative controls (unstimulated/untreated, Dextrose Control, PBS Control), 1 µg/ml AmBisome or 1 mg/ml Feraheme for 24 h. Dextrose was a control for AmBisome and PBS was a control for Feraheme. (A) The top heat map indicates the stimulation index (SI) of percentage of treated cell populations (AmBisome or Feraheme) as compared to unstimulated (or untreated) populations for each of the three human donors—each donor had two replicates for each condition. Cell population percentages were defined as percentage of live cells. The middle heat map is a representative heat map of the average percentage of cells in each of the different activation quadrants for monocyte, pDC, mDC and NK cells from Donor O4Q7(2 replicates per condition). The bottom heat map is a representative heat map from Donor O4Q7 (2 replicates per condition) indicating the average stimulation index of the geometric mean fluorescence intensity (gMFI) of the activation markers in each cell population as compared to the unstimulated cells. (B) Tables representing the average stimulation indices of the different cell populations as compared to the unstimulated PBMC for each of the three donors (2 replicates per condition for each of the 3 donors). The top table indicates changes in cell populations. The next four tables indicate fold changes in percentages of activated cells in monocyte, pDC, mDC and NK cell populations and the last four tables indicate the fold changes for gMFI of activated cells in monocyte, pDC, mDC and NK cell populations.